Interestingly, MGD011 is also able to kill venetoclax-resistant CLL cells, through a mechanisms that is independent from Bcl-2-mediated apoptosis (236, 237). This evidence concerns the gene BCL2 and B-cell chronic lymphocytic leukemia.